Top Banner
Problems of Polypharmacy Dr Nivi Singh Elderly Care Department
34

Problems of Polypharmacy

Jan 11, 2016

Download

Documents

vashon

Problems of Polypharmacy. Dr Nivi Singh Elderly Care Department. Definition. Multiple drug use by patients 4 or more medications. Elderly. Medication use increases with age Over 60s - 19% of the population 57% of dispensed prescriptions Over 70s - 20% taking > 5 medications. Causes. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Problems of Polypharmacy

Problems of Polypharmacy

Dr Nivi Singh

Elderly Care Department

Page 2: Problems of Polypharmacy

Definition

• Multiple drug use by patients

• 4 or more medications

Page 3: Problems of Polypharmacy

Elderly

• Medication use increases with age

• Over 60s - 19% of the population

• 57% of dispensed prescriptions

• Over 70s - 20% taking > 5 medications

Page 4: Problems of Polypharmacy

Causes

• Appropriate

• Inappropriate

Page 5: Problems of Polypharmacy

Appropriate

• Multiple medical problems

• New drugs for previously untreatable dx

• Proof of efficacy of treatment in elderly

Page 6: Problems of Polypharmacy

Usually/always Inappropriate

Multiple drug prescribers• Direct relationship btn the number of prescribing

physicians and the incidence of ADRs• Non-medical prescribing

No regular medication review

Prescribing cascade

Prescribing of drugs that are not indicated

Page 7: Problems of Polypharmacy

Patient factors

• Inaccurate drug history

• Underreporting of symptoms

• Hoarding medications

• Reluctance to discontinue medication

Page 8: Problems of Polypharmacy

Associations

• Adverse drug reactions

• Reduced compliance - > 2daily doses or >3 different drugs

• Poor quality of life

• High rate of symtomatology

• Hospital admission

• Longer length of stay

Page 9: Problems of Polypharmacy

Associations

• Increased mortality

• Readmission on discharge

• Drug expense

Page 10: Problems of Polypharmacy

Adverse Drug Reaction

A response to a drug that is:

noxious and unintended

occurs in doses normally used for the

treatment, prophylaxis, or diagnosis of

disease, or the modification of physiological function (WHO)

Page 11: Problems of Polypharmacy

ADRs

• Increase morbidity and mortality

• Underestimated

• Implicated in ~17% hospital admissions

• ~30% of elderly pts exposed to drugs that may interact with one another

Page 12: Problems of Polypharmacy

ADRs

The most consistent risk factor for an ADR is:

Number of drugs being taken

ADR rate 1.2% with 1 drug

10% with 9 drugs

50% with 10 drugs

Page 13: Problems of Polypharmacy
Page 14: Problems of Polypharmacy

Mechanisms of altered drug response in the elderly

Page 15: Problems of Polypharmacy

Changes with age

Altered drug pharmacokinetics• changes in absorption, distribution,

metabolism and excretion

Altered drug pharmacodynamics• altered tissue sensitivity

Page 16: Problems of Polypharmacy

Volume of Distribution

• Increased % of body fat

• Reduced lean body mass

• Reduced total body water (15%)

Page 17: Problems of Polypharmacy

Changes in protein binding

Decrease in plasma proteins

• reduced protein bound (inactive) drug • greater amount of free (active) drug • increased drug effect, potentially

resulting in toxicity

Page 18: Problems of Polypharmacy

Metabolism

• Reduction in hepatic blood-flow and mass

• Hepatic clearance of many drugs is reduced

• Care - drugs with a narrow therapeutic range that are metabolised by the liver (eg. warfarin, phenytoin, theophylline)

Page 19: Problems of Polypharmacy

Excretion

• Fall in GFR and creatinine clearance

• Reduces elimination of many drugs

• Care - narrow therapeutic range drugs eliminated partially or totally by the kidney (eg. digoxin, lithium and aminoglycoside antibiotics)

Page 20: Problems of Polypharmacy

Pharmacodynamics

• Changes occur in end-organ responsiveness to medications

• Due to alterations in receptors and homeostatic mechanisms

• e.g. an increased receptor response is seen for benzodiazepines, opiates, and warfarin

• Increased likelihood of an ADR

Page 21: Problems of Polypharmacy

Drugs that commonly produce adverse effects in elderly

Page 22: Problems of Polypharmacy

Categories of medication

Medication Category

Cardiovascular

% enrollees

53

Antibiotics 45

Diuretics 30

Opioids 22

Non-opioid analgesics 20

Antidepressants 13

Sedatives and hypnotics

Anticoagulants

13

7

Page 23: Problems of Polypharmacy

Recognising ADRs

• Constipation• Confusion• Dizziness• Depression• Incontinence• Nausea• Unsteadiness

Page 24: Problems of Polypharmacy

Falls

Increased risk of falls

• Polypharmacy is a marker of underlying comorbidity

• High risk medications

Page 25: Problems of Polypharmacy

Benefits of reducing polypharmacy

• Reduced ADRs

• Improved compliance

• Improved patient quality of life

• Reduced hospital admissions

• Lower risk of drug interactions

• Fewer drug errors

• Reduced prescribing costs

Page 26: Problems of Polypharmacy

NSF

• Gain the max benefit from their medication to increase their quality and duration of life

• Avoid excessive, inappropriate, or inadequate consumption of medicines

Page 27: Problems of Polypharmacy

Solutions

Page 28: Problems of Polypharmacy

Basic principles of good prescribing

• Accurate diagnosis

• Non-pharmacological agent

• Start with lowest dose – Start low; Go slow

• Consider potential side-effects and their impact

• Review entire medication regimen

Page 29: Problems of Polypharmacy

Regular medication review

• >4 medications 6-monthly review

• < 4 medications annual review

• Full drug history

• Over-the-counter medication

• Alternative drug therapies

Page 30: Problems of Polypharmacy

Alternative drug therapies

• Gingko, garlic and ginseng – all interact with warfarin and possibly aspirin

• Alcohol - exacerbates drug-induced hypotension or sedation

• Many commonly prescribed medications have the potential to interact with alcohol

Page 31: Problems of Polypharmacy

Medication Review

• Identify unnecessary drugs

• Review dose

• Once daily / once weekly formulations

Page 32: Problems of Polypharmacy

Medication Review

• Non-pharmacological interventions

• Enlist family/friends as needed

• Medication organisation equipment

• Variety of healthcare professionals

• Information technology

Page 33: Problems of Polypharmacy

Patient Education

• Written information

• Take drugs as prescribed

• Do not use medication from others

• Report symptoms

• Report all drugs used

Page 34: Problems of Polypharmacy

Conclusion

• Common and growing problem

• Inappropriate and appropriate prescribing

• Benefits of reducing the drug burden

• Regular medication review

• Not always avoidable –minimise unnecessary multiple drugs